Increased expression of TGF-β receptors by scleroderma fibroblasts: Evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype

Journal of Investigative Dermatology

Volumn 110, Issue 1, 1998, Pages 47-51

  Kawakami, T ^a   Ihn, H ^a   Xu, W ^a   Smith, E ^a   LeRoy, C ^a   Trojanowska, M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Collagen type I; Fibrosis

Indexed keywords

COLLAGEN TYPE 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; DRUG RECEPTOR BINDING; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; SCLERODERMA; SKIN FIBROBLAST;

EID: 0031886413     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00073.x     Document Type: Chapter

References (38)

1. D. Abraham S. Lupoli A. McWhirter Expression and function of surface antigens on scleroderma fibroblasts Arthritis Rheum 34 1991 1164 1172
2. L. Attisano WranaJL, López-Casillas F Massagué J: TGF-β receptors and actions. Biochimica Biophysica Acta 1222 1994 71 80
3. W.A. Border E. Ruoslahti Transforming growth factor-β in disease: The dark side of tissue repair J Clin Invest 90 1992 1 7
4. G. Bou-Gharios J. Osman C. Black I. Olsen Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis Clin Chim Acta 231 1994 69 78
5. T. Brandt W.R. MacLellan M.D. Schneider A dominant-negative receptor for type β transforming growth factors created by deletion of the kinase domain J Biol Chem 268 1993 11500 11503
6. R.B. Buckingham R.K. Prince G.P. Rodnan F. Taylor Increased collagen accumulation in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma) J Lab Clin Med 92 1978 5 21
7. M.R. Duncan A. Hasan B. Berman Oncostatin M stimulates collagen and glycosoamican production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts J Invest Dermatol 104 1995 128 133
8. B. Eckes C. Mauch G. Huppe T. Krieg Differential regulation of transcription and transcript stability of pro-α1 (I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma Biochem J 315 1996 549 554
9. V. Falanga S.L. Tiegs S.P. Alstadt A.B. Roberts M.B. Sporn Transforming growth factor beta: Selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis J Invest Dermatol 89 1987 100 104
10. C.A. Feghali K.L. Bost D.W. Boulware L.S. Levy Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis Autoimmun 17 1994 309 318
11. X.-H. Feng R. Derynck Ligand-independent activation of transforming growth factor (TGF-) β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors J Biol Chem 271 1996 13123 13129
12. E.G. Hitraya S.A. Jimenez Transcriptional activation of the α1 (I) procollagen gene in systemic sclerosis dermal fibroblasts Arthritis Rheum 39 1996 1347 1354
13. Y. Ichiki E. Smith E.C. LeRoy M. Trojanowska Different effects of basic fibroblast growth factor and transforming growth factor-β on the two platelet-derived growth factor receptors’ expression in scleroderma and healthy human fibroblasts J Invest Dermatol 104 1995 124 127
14. A. Jelaska M. Arakawa G. Broketa Korn JH: heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts Arthritis Rheum 39 1996 1338 1346
15. S.A. Jimenez G. Feldman R.I. Bashey R. Bienkowski J. Rosenbloom Co-ordinate increase in the expression of type I and Type III collagen genes in progressive systemic sclerosis fibroblasts Biochem J 237 1986 837 843
16. Y. Kawaguchi IL-1a gene expression and protein production by fibroblasts’ from patients with systemic sclerosis Clin Exp Immunol 97 1994 445 450
17. K. Kikuchi E.A. Hartl E.A. Smith E.C. LeRoy M. Trojanowska Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF-β stimulation Biochem Biophys Res Comm 187 1992 45 50
18. K. Kikuchi A. Yamakage E.A. Smith E.C. LeRoy M. Trojanowska Differential modulation of bFGF receptors by TGF-β in adult skin, scleroderma skin, and newborn foreskin fibroblasts J Invest Dermatol 99 1992 201 205
19. K. Kikuchi M. Kubo S. Sato M. Fujimoto K. Tamaki Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis J Am Acad Dermatol 33 1995 973 978
20. T.Z. Kirk M.E. Mark C.C. Chua B.H. Chua M.D. Mayes Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1 J Biol Chem 270 1995 3423 3428
21. M. Kulozik A. Hogg B. Lankat-Buttgereit T. Krieg Co-localization of transforming growth factor β2 with α1 (I) procollagen mRNA in tissue sections of patients with systemic sclerosis J Clin Invest 86 1990 917 922
22. K.S. Lee Y.J. Ro Y.W. Ryoo H.J. Kwon J.Y. Song Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture J Dermatol Sci 12 1996 110 117
23. E.C. LeRoy Increased collagen synthesis by scleroderma skin fibroblasts in vitro J Clin Invest 54 1974 880 889
24. E.C. LeRoy Systemic sclerosis (scleroderma) J.B. Wyngaarden L.H. Smith J.C. Bennett Cecil Textbook of Medicine 19th edn. 1992 W.B. Saunders Philadelphia 1530 1535
25. E.C. LeRoy E.A. Smith M.B. Kahaleh M. Trojanowska R. Silver A Strategy for determining the pathogenesis of systemic sclerosis Arthritis Rheum 32 1989 817 825
26. L. Lillien Changes in retinal cell fate induced by overexpression of EGF receptor Nature 1995 158 162
27. J. Massagué The transforming growth factor-β family Annu Rev Cell Biol 6 1990 597 641
28. A. McWhirter P. Colosetti K. Rubin K. Miyazono C. Black Collagen type I is not under autocrine control by transforming growth factor-β1 in normal and scleroderma fibroblasts Lab Invest 71 1994 885 894
29. E.V. Obberghen-Schilling N.S. Roche K.C. Flanders M.B. Sporn A.B. Roberts Transforming growth factor β1 positively regulates its own expression in normal and transformed cells J Biol Chem 263 1988 7741 7746
30. J. Peltonen L. Kahari J. Uitto S.A. Jimenez Increased expression of type VI collagen genes in systemic sclerosis Arthritis Rheum 33 1990 1829 1835
31. G. Piccini M.M. Luchetti M.L. Caniglia A.M. Carossino M. Montroni M. Introna Gabrieli A: c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts, and unlike B-myb gene, does not correlate with proliferation J Invest Dermatol 106 1996 1281 1286
32. L. Rudnicka J. Varga A.M. Christiano R.V. Iozzo S.A. Jimenez J. Uitto Elevated expression of type VI collagen in the skin of patients with systemic sclerosis: regulation of transforming growth factor β J Clin Invest 93 1994 1709 1715
33. T. Tamaki K. Ohnishi C. Hartl E.C. LeRoy M. Trojanowska Characterization of a GC-rich region containing Sp1 binding site (s) as a constitutive responsive element of the α2 (I) collagen gene in human fibroblasts J Biol Chem 270 1995 4299 4304
34. M. Trojanowska L. Wu E.C. LeRoy Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts Oncogene 3 1988 477 481
35. B. White-Needleman J. Choi A. Burrows-Mezu J.A. Fontana Secretion and binding of transforming growth factor β by scleroderma and normal dermal fibroblasts Arthritisritis Rheum 33 1990 650 656
36. W. Xu E.C. LeRoy E.A. Smith Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-β J Rheumatol 18 1991 241 246
37. A. Yamakage K. Kikuchi E.A. Smith E.C. LeRoy M. Trojanowska Selective upregulation of platelet-derived growth factor a receptors by transforming growth factor β in scleroderma fibroblasts J Exp Med 175 1992 1227 1234
38. H. Yamamoto H. Ueno A. Ooshima Takeshita A: adenovirus-mediated Transfer of a truncated transforming growth factor-β (TGF-β) type II receptor completely and specifically abolishes diverse signaling by TGF-β in vascular wall cells in primary culture J Biol Chem 271 1996 16253 16259